Correlation Between Centessa Pharmaceuticals and ScanSource

Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and ScanSource at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and ScanSource into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and ScanSource, you can compare the effects of market volatilities on Centessa Pharmaceuticals and ScanSource and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of ScanSource. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and ScanSource.

Diversification Opportunities for Centessa Pharmaceuticals and ScanSource

0.03

Correlation Coefficient

Centessa Pharmaceuticals  ScanSource

Significant diversification

The 3 months correlation between Centessa and ScanSource is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and ScanSource in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ScanSource and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with ScanSource. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ScanSource has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and ScanSource go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and ScanSource

Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 1.54 times more return on investment than ScanSource. However, Centessa Pharmaceuticals is 1.54 times more volatile than ScanSource. It trades about -0.03 of its potential returns per unit of risk. ScanSource is currently generating about -0.2 per unit of risk. If you would invest  1,635  in Centessa Pharmaceuticals PLC on December 30, 2024 and sell it today you would lose (176.00) from holding Centessa Pharmaceuticals PLC or give up 10.76% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Centessa Pharmaceuticals PLC  vs.  ScanSource

Centessa Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Centessa Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

ScanSource

Risk-Adjusted Performance

Very Weak

Over the last 90 days ScanSource has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Centessa Pharmaceuticals and ScanSource

The main advantage of trading using opposite Centessa Pharmaceuticals and ScanSource positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, ScanSource can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ScanSource will offset losses from the drop in ScanSource's long position.

The idea behind Centessa Pharmaceuticals PLC and ScanSource pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.